Urology
Volume 57, Issue 4, Supplement 1 , Pages 64-67, April 2001

Androgen antagonists: Potential role in prostate cancer prevention

  • Donald L Trump

      Affiliations

    • University of Pittsburgh, Pittsburgh, Pennsylvania, USA (DLT)
    • Corresponding Author InformationReprint requests: Donald L. Trump, MD, Department of Medicine and Urology, University of Pittsburgh, 200 Lothrop Street, N 723 MUH, Pittsburgh, PA 15213
    • ,
  • Joanne A Waldstreicher

      Affiliations

    • Merck & Co., Rahway, New Jersey, USA (JAW)
    • Dr. Waldstreicher holds stock in Merck & Co., Inc. Dr. Kolvenbag holds stock in AstraZeneca. Dr. Neubauer holds stock in Eli Lilly & Company and is a patent inventor of some of the reagents described herein.
    • ,
  • Geert Kolvenbag

      Affiliations

    • AstraZeneca, Wilmington, Delaware, USA (GK)
    • Dr. Waldstreicher holds stock in Merck & Co., Inc. Dr. Kolvenbag holds stock in AstraZeneca. Dr. Neubauer holds stock in Eli Lilly & Company and is a patent inventor of some of the reagents described herein.
    • ,
  • Paul S Wissel

      Affiliations

    • Glaxo Wellcome Inc., Research Triangle Park, North Carolina, USA (PSW)
    • ,
  • Blake L Neubauer

      Affiliations

    • Eli Lilly and Company, Indianapolis, Indiana, USA (BLN)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(00)00943-2

Urology
Volume 57, Issue 4, Supplement 1 , Pages 64-67, April 2001

Article Tools